Effect of Vascular Endothelial Growth Factor and Erythropoietin on Functional Activity of Fibroblasts and Multipotent Mesenchymal Stromal Cells
- Авторы: Bondarenko N.1,2, Nikonorova Y.1, Surovtseva M.1, Lykov A.1,2, Poveshchenko O.1,2, Poveshchenko A.1,2, Pokushalov E.2, Romanov A.2, Konenkov V.1,2
-
Учреждения:
- Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
- E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
- Выпуск: Том 160, № 4 (2016)
- Страницы: 498-501
- Раздел: Experimental Biology
- URL: https://journals.rcsi.science/0007-4888/article/view/236755
- DOI: https://doi.org/10.1007/s10517-016-3206-8
- ID: 236755
Цитировать
Аннотация
The study examined the effect of VEGF and erythropoietin on proliferative and migratory activities of skin fibroblasts and multipotent mesenchymal stromal cells of human adipose tissue. VEGF stimulated proliferation and migration of fi broblasts, but produced no significant effect on functional activity of multipotent mesenchymal stem cells. Erythropoietin stimulated proliferation of both cell types, but did not affect their migration.
Об авторах
N. Bondarenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Автор, ответственный за переписку.
Email: bond802888@yandex.ru
Россия, Moscow; Novosibirsk
Yu. Nikonorova
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Россия, Moscow
M. Surovtseva
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences
Email: bond802888@yandex.ru
Россия, Moscow
A. Lykov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Россия, Moscow; Novosibirsk
O. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Россия, Moscow; Novosibirsk
A. Poveshchenko
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Россия, Moscow; Novosibirsk
E. Pokushalov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Россия, Novosibirsk
A. Romanov
E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Россия, Novosibirsk
V. Konenkov
Research Institute of Experimental and Clinical Lymphology, Siberian Division of the Russian Academy of Medical Sciences; E. N. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health of the Russian Federation
Email: bond802888@yandex.ru
Россия, Moscow; Novosibirsk